E-LIB Suche - Ergebnisse für: Ochoa-de-Olza, Maria - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

A phase Ib/II study of galunisertib in combination with niv..:

Nadal, Ernest ; Saleh, Mansoor ; Aix, Santiago Ponce...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386782/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Li..:

Lozano-Rabella, Maria ; Garcia-Garijo, Andrea ; Palomero, Jara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261919/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Schöffski, Patrick ; Tan, Daniel S W ; Martín, Miguel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883259/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Low-dose irradiation for reversing immunotherapy resistance..:

Ochoa-de-Olza, Maria ; Bourhis, Jean ; Coukos, George.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289035/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Tumor-Associated Microbiome: Where Do We Stand?:

Oliva, Marc ; Mulet-Margalef, Nuria ; Ochoa-De-Olza, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867144/. , 2021

Link: http://www.ncbi.nlm.nih...

6

Frequency and characteristics of familial melanoma in Spain..:

Marques-Rodas, I. (Iván) ; Martin-Gonzalez, M. (Manuel) ; Nagore, E. (Eduardo)...
https://hdl.handle.net/10171/38273. , 2015

Link: https://hdl.handle.net/1..

7

Table1_Dual inhibition of MEK and PI3Kβ/δ–a potential thera..:

Vicenç Ruiz de Porras ; Adrià Bernat-Peguera ; Clara Alcon...
doi:10.3389/fphar.2024.1331648.s001. , 2024

Link: https://doi.org/10.3389/..

8

Table1_Dual inhibition of MEK and PI3Kβ/δ–a potential thera..:

Vicenç Ruiz de Porras ; Adrià Bernat-Peguera ; Clara Alcon...
doi:10.3389/fphar.2024.1331648.s001. , 2024

Link: https://doi.org/10.3389/..

9

Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic ..:

Vicenç Ruiz de Porras ; Adrià Bernat-Peguera ; Clara Alcon...
https://www.frontiersin.org/articles/10.3389/fphar.2024.1331648/full. , 2024

Link: https://doi.org/10.3389/..

10

Table1_Dual inhibition of MEK and PI3Kβ/δ–a potential thera..:

Vicenç Ruiz de Porras ; Adrià Bernat-Peguera ; Clara Alcon...
doi:10.3389/fphar.2024.1331648.s001. , 2024

Link: https://doi.org/10.3389/..

11

Prognostic Role of Neutrophil, Monocyte and Platelet to Lym..:

Andrea Plaja ; Iris Teruel ; Maria Ochoa-de-Olza...
https://www.mdpi.com/1422-0067/24/14/11420. , 2023

Link: https://doi.org/10.3390/..

12

Prognostic Role of Neutrophil, Monocyte and Platelet to Lym..:

Andrea Plaja ; Iris Teruel ; Maria Ochoa-de-Olza...
Molecular Oncology. , 2023

Link: https://doi.org/10.3390/..

13

A phase Ib/II study of galunisertib in combination with niv..:

Ernest Nadal ; Mansoor Saleh ; Santiago Ponce Aix...
https://doi.org/10.1186/s12885-023-11153-1. , 2023

Link: https://doi.org/10.1186/..

14

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Tian Zhang ; Filippo de Braud ; Taito Esaki...
https://jitc.bmj.com/content/10/2/e003776.full. , 2022

Link: https://doi.org/10.1136/..

15

Low-dose irradiation for reversing immunotherapy resistance..:

María Ochoa-de-Olza ; Jean Bourhis ; Fernanda G Herrera
https://jitc.bmj.com/content/10/7/e004939.full. , 2022

Link: https://doi.org/10.1136/..

1-15